Abdelmoneim, E. (2020). Cholestatic hepatitis in patient treated by carbimazole: A case report. Medical Journal of Viral Hepatitis, 4.2(2), 53-55. doi: 10.21608/mjvh.2020.80648
Elhadidy Abdelmoneim. "Cholestatic hepatitis in patient treated by carbimazole: A case report". Medical Journal of Viral Hepatitis, 4.2, 2, 2020, 53-55. doi: 10.21608/mjvh.2020.80648
Abdelmoneim, E. (2020). 'Cholestatic hepatitis in patient treated by carbimazole: A case report', Medical Journal of Viral Hepatitis, 4.2(2), pp. 53-55. doi: 10.21608/mjvh.2020.80648
Abdelmoneim, E. Cholestatic hepatitis in patient treated by carbimazole: A case report. Medical Journal of Viral Hepatitis, 2020; 4.2(2): 53-55. doi: 10.21608/mjvh.2020.80648
Cholestatic hepatitis in patient treated by carbimazole: A case report
Gastroetetro- and Hepatology dept., Damietta fever hospital, Egypt
Abstract
Antithyroid drugs are the treatment option for toxic multinodular goiter (TNG). Carbimazole is generally the drug of choice except in pregnancy where propylthiouracil is used. It is well tolerated and common side effects include allergy, gastrointestinal disorder, and rarely agranulocytosis. Hepatitis is another rare but serious complication. We reported a case of 43 years female diagnosed as hyperthyroidism, who developed cholestatic hepatitis and skin manifestation after carbimazole treatment for 2 months. She recovered completely following withdrawal of the drug and steroid therapy.